Antisense oligonucleotides (ASOs) are short single stranded synthetic RNA or DNA
molecules, whereas double-stranded RNA nucleotide sequences are called small …

Hepatic steatosis, the buildup of neutral lipids in lipid droplets (LDs), is commonly referred to
as metabolic dysfunction-associated steatotic liver disease (MASLD) when alcohol or viral …

Background: NAFLD has become the leading cause of chronic liver disease worldwide
afflicting about one quarter of the adult population. NASH is a severe subtype of NAFLD …

Hepatocellular carcinoma (HCC) is one of the most fatal and fastest growing malignancies.
Recently, nonalcoholic steatohepatitis (NASH), characterized by liver steatosis …

The primary hepatic consequence of obesity is non-alcoholic fatty liver disease (NAFLD),
affecting about 25% of the global adult population. Non-alcoholic steatohepatitis (NASH) is a …

Background & Aims Hepatocellular carcinoma (HCC) is one of the most fatal and fastest-
growing cancers. Recently, nonalcoholic steatohepatitis (NASH) has been recognized as a …

Nonalcoholic fatty liver disease (NAFLD) has emerged as a leading cause of chronic liver
disease worldwide, primarily because of the massive global increase in obesity. Despite …

As the body's critical metabolic organ, the liver plays an essential role in maintaining proper
body homeostasis. However, as people's living standards have improved and the number of …

Nuclear factor E2-associated factor 2 (Nrf2)/Antioxidant Response Element (ARE) signaling
pathway is an endogenous antioxidant pathway that protects cells from oxidative damage …

Metabolic dysfunction–associated steatotic liver disease has emerged as a leading global
cause of chronic liver disease. Our recent translational investigations have shown that the …